# IRCCS Ospedale San Raffaele

Source: https://onco.cc/institutions/san-raffaele/  
OnCo record `san-raffaele` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Milan's research hospital known for engineered T-cell therapies, gene therapy, high-volume pancreatic surgery and HER2 breast cancer trials.

## Summary

Ospedale San Raffaele is a private IRCCS research hospital with its own university and a strong gene and cell therapy tradition through the San Raffaele Telethon Institute for Gene Therapy. Fabio Ciceri's haematology and transplant unit and Chiara Bonini's experimental haematology laboratory developed suicide-gene-modified donor lymphocytes and TCR-edited T cells, Luca Gianni's breast oncology programme led the NeoSphere trial of dual HER2 blockade with pertuzumab and trastuzumab, and Massimo Falconi's pancreatic surgery unit is among Europe's highest-volume centres. The hospital runs neuro-oncology, urology, radiotherapy and a phase 1 unit, and pathology under Claudio Doglioni supports genomics-driven trials.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: San Raffaele Hospital; OSR; Università Vita-Salute San Raffaele
- City: Milan, IT
- Type: hospital
- Website: https://www.hsr.it

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/San_Raffaele_Hospital
- Homepage: https://www.hsr.it
- Research: https://research.hsr.it

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [Neuroendocrine tumours](https://onco.cc/cancers/neuroendocrine/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Allogeneic (off-the-shelf) cell therapy](https://onco.cc/technologies/allogeneic-cell-therapy/), [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [Robotic & minimally invasive surgery](https://onco.cc/technologies/robotic-surgery/), [TCR-T cell therapy](https://onco.cc/technologies/tcr-t/)
- targets: [HER2](https://onco.cc/targets/her2/)
- drugs: [Trastuzumab](https://onco.cc/drugs/trastuzumab/)
- institutions: [Fondazione IRCCS Istituto Nazionale dei Tumori](https://onco.cc/institutions/int-milan/), [IEO (European Institute of Oncology)](https://onco.cc/institutions/ieo-milan/)
- people: [Andrea Necchi](https://onco.cc/people/andrea-necchi/), [Andrés J. M. Ferreri](https://onco.cc/people/andres-ferreri/), [Gianvito Martino](https://onco.cc/people/gianvito-martino/), [Marco Centenari](https://onco.cc/people/marco-centenari/)

---
JSON: https://onco.cc/api/v1/entities/san-raffaele.json